Data Insights
Artificial Intelligence (10)
Big Data (4)
Biosimilars (5)
Blockchain (1)
Cell & Gene Therapy (13)
Chemotherapy (1)
Cloud (1)
Corporate Governance (3)
Covid-19 (5)
Cybersecurity (4)
Digitalization (2)
Easy & Affordable (1)
Electronic Medical Record (EMR) Systems (1)
Environmental Sustainability (6)
Future of Work (2)
Genomics (10)
Health & Wellness (1)
Immuno-oncology (19)
Immunotherapy (1)
Internet of Things (2)
Microbiome (1)
Mobile Health (1)
Nanomedicine (2)
Oncology (4)
Orphan Designated Drugs (4)
Other Innovation Areas (87)
Precision and Personalized Medicine (1)
Remote Patient Monitoring (1)
Renewable Energy (1)
Robotics (2)
Small molecules (1)
Smart Hospitals (2)
Social Responsibility (3)
Virtual Care (3)
Showing 2 results out of 2
Q4 2023 update: nanomedicine related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that nanomedicine accounted for 7 pharmaceutical deals announced in Q4 2023,...
Nanomedicine: the leading companies in mRNA delivery lipid nanoparticles revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...